Warmuth; Markus

Patent Applications and Registrations

Patent applications and USPTO patent grants for Warmuth; Markus.The latest application filed is for "combination comprising at least one spliceosome modulator and at least one inhibitor chosen from bcl2 inhibitors, bcl2/bclxl inhibitors, and bclxl inhibitors and methods of use".

Company Profile

4.17.31

Warmuth; Markus - Cambridge MA
WARMUTH; Markus - Newton MA
Warmuth; Markus - Natick MA
Warmuth; Markus - San Marcos CA
Warmuth; Markus - Starnberg DE
Warmuth, Markus - Munchen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Organic compositions to treat HSF1-related diseases Grant 11,091,761 - Hinkle , et al. August 17, 2	2021-08-17
Combination Comprising At Least One Spliceosome Modulator And At Least One Inhibitor Chosen From Bcl2 Inhibitors, Bcl2/bclxl Inhibitors, And Bclxl Inhibitors And Methods Of Use App 20200352937 - AIRD; Daniel ; et al.	2020-11-12
Spliceosome Mutations And Uses Thereof App 20200190593 - WARMUTH; Markus ; et al.	2020-06-18
Organic Compositions To Treat Hsf1-related Diseases App 20190276827 - Hinkle; Gregory ; et al.	2019-09-12
Organic compositions to treat HSF1-related diseases Grant 10,287,582 - Hinkle , et al.	2019-05-14
Organic Compositions To Treat Beta-catenin-related Diseases App 20180282728 - Bettencourt; Brian Richard ; et al.	2018-10-04
Organic compositions to treat beta-catenin-related diseases Grant 10,023,862 - Bettencourt , et al. July 17, 2	2018-07-17
Organic Compositions To Treat Kras-related Diseases App 20180153919 - Bettencourt; Brian ; et al.	2018-06-07
Organic Compositions To Treat Hsf1-related Diseases App 20170073678 - Hinkle; Gregory ; et al.	2017-03-16
Organic compositions to treat HSF1-related diseases Grant 9,540,643 - Hinkle , et al. January 10, 2	2017-01-10
Organic Compositions To Treat Beta-catenin-related Diseases App 20150291954 - Bettencourt; Brian Richard ; et al.	2015-10-15
Organic Compositions To Treat Hsf1-related Diseases App 20150284721 - HINKLE; Gregory ; et al.	2015-10-08
Organic Compositions To Treat Kras-related Diseases App 20150238515 - Bettencourt; Brian ; et al.	2015-08-27
Organic compositions to treat HSF1-related diseases Grant 9,096,637 - Hinkle , et al. August 4, 2	2015-08-04
Use of a PKC inhibitor Grant 8,748,428 - Schuler , et al. June 10, 2	2014-06-10
Organic Compositions To Treat Hsf1-related Diseases App 20140039039 - HINKLE; Gregory ; et al.	2014-02-06
Organic compositions to treat HSF1-related diseases Grant 8,623,838 - Chen , et al. January 7, 2	2014-01-07
Methods And Compositions For Treating Cancers App 20130210771 - Dierks; Christine ; et al.	2013-08-15
Biphenylcarboxamide derivatives as hedgehod pathway modulators Grant 8,507,471 - Dierks , et al. August 13, 2	2013-08-13
Organic compositions to treat HSF1-related diseases Grant 8,481,509 - Hinkle , et al. July 9, 2	2013-07-09
Organic compositions to treat HSF1-related diseases Grant 8,293,718 - Hinkle , et al. October 23, 2	2012-10-23
Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia Grant 8,268,837 - Donato , et al. September 18, 2	2012-09-18
Methods And Compositions For Treating Cancers App 20120165355 - Warmuth; Markus ; et al.	2012-06-28
Organic Compositions To Treat Hsf1-related Diseases App 20120129914 - HINKLE; Gregory ; et al.	2012-05-24
Organic Compositions To Treat Hsf1-related Diseases App 20120129915 - HINKLE; Gregory ; et al.	2012-05-24
Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia Grant 8,119,649 - Donato , et al. February 21, 2	2012-02-21
Use Of A Pkc Inhibitor App 20110245256 - SCHULER; Walter ; et al.	2011-10-06
Organic Compositions To Treat Hsf1-related Diseases App 20110166058 - HINKLE; Gregory ; et al.	2011-07-07
Organic Compounds App 20110129852 - Barthe; Christophe ; et al.	2011-06-02
Methods And Compositions For Treating Lymphoma And Myeloma App 20110044991 - Dierks; Christine ; et al.	2011-02-24
Compositions And Methods For Treating Cancers App 20110021524 - Adrian; Francisco ; et al.	2011-01-27
Methods And Compositions For Treating Cancers App 20100216828 - Dierks; Christine ; et al.	2010-08-26
Biphenylcarboxamide Derivatives As Hedgehod Pathway Modulators App 20100197659 - Dierks; Christine ; et al.	2010-08-05
Use Of C-src Inhibitors Alone Or In Combination With Sti571 For The Treatment Of Leukaemia App 20090227608 - Donato; Nicholas J. ; et al.	2009-09-10
Organic Compounds App 20090191606 - Barthe; Christophe ; et al.	2009-07-30
Use Of C-src Inhibitors Alone Or In Combination With Sti571 For The Treatment Of Leukaemia App 20070149539 - Donato; Nicholas J. ; et al.	2007-06-28
Use of c-Src inhibitors alone or in combinaton with STI571 for the treatment of leukaemia App 20070027167 - Donato; Nicholas J. ; et al.	2007-02-01
Organic compounds App 20060148058 - Barthe; Christophe ; et al.	2006-07-06
Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia App 20060074094 - Donato; Nicholas J. ; et al.	2006-04-06
Use of c-src inhibitors alone or in combination with st1571 for the treatment of leukaemia App 20040248906 - Donato, Nicholas J ; et al.	2004-12-09
Organic compounds App 20030170851 - Barthe, Christophe ; et al.	2003-09-11
Method for selecting enzyme inhibitors App 20030162222 - Warmuth, Markus ; et al.	2003-08-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.